Earnings History Data for Entera Bio (ENTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Entera Bio
Entera Bio Ltd. is a clinical-stage biopharmaceutical company. It focused on the development and commercialization of orally delivered molecule therapeutics for use in orphan indications and other areas with significant unmet medical need. The Company is initially applying its technology to develop an oral formulation of parathyroid hormone for hypoparathyroidism and osteoporosis. Entera Bio Ltd. is based in Jerusalem, Israel.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08-11-2024 | AH | ENTX | Entera Bio | 62.00 | -0.08 | -0.05 | 0.00 | Entera Bio GAAP EPS of -$0.08 misses by $0.03, revenue of $0.04M in-line [11/8/2024 5:30 PM] |
1.76 | 0.04 (2.33%) |
1.64 | -0.08 (-4.65%) |
0.52 - 3.35 | 81,992 | 20,000 | 2,469 | ||
| 08-03-2024 | AH | ENTX | Entera Bio | 39.00 | -0.07 | -0.08 | 0.00 | Entera Bio GAAP EPS of -$0.31 beats by $0.01 [3/8/2024 4:13 PM] |
1.46 | 0.07 (5.04%) |
1.44 | 0.05 (3.60%) |
0.52 - 1.87 | 56,785 | 210,000 | 500 | ||
|
|
||||||||||||||||||
| 14-11-2023 | PM | ENTX | Entera Bio | 20.00 | -0.08 | -0.09 | 0.00 | Entera Bio GAAP EPS of -$0.08 [11/14/2023 8:46 AM] |
0.70 | 0.0 (0.00%) |
0.72 | 0.02 (2.50%) |
0.52 - 1.48 | 44,729 | 40,000 | 1,100 | ||
| 05-05-2023 | AH | 4:15 PM ET (May 5) |
ENTX | Entera Bio | 25.00 | -0.08 | -0.12 | 0.00 | Entera Bio GAAP EPS of -$0.08 beats by $0.04 [5/5/2023 4:21 PM] |
0.88 | 0.06 (7.30%) |
0.82 | 0.0 (0.00%) |
0.47 - 2.57 | 63,519 | 50,000 | 18,268 | |
| 03-04-2023 | PM | ENTX | Entera Bio | 39.00 | -0.10 | -0.12 | 0.00 | Entera Bio GAAP EPS of -$0.45 [4/3/2023 12:51 AM] |
1.02 | -0.14 (-12.07%) |
1.14 | -0.02 (-1.72%) |
0.47 - 3.00 | 217,405 | 100,000 | 7,183 | ||
| 11-08-2022 | PM | 8:00 AM ET (Aug 11) |
ENTX | Entera Bio | 42.00 | -0.11 | -0.13 | 0.00 | Entera Bio GAAP EPS of -$0.24 , revenue of $0.11M [8/11/2022 8:59 AM] |
3.76 | -0.21 (-5.29%) |
1.97 | 0.09 (4.79%) |
3.68 - 12.42 | 14,481 | 20,000 | 760 | |
| 12-05-2022 | PM | 0:00 AM ET (May 12) |
ENTX | Entera Bio Ltd. | 39.75 | -0.13 | -0.16 | -0.43 | Entera Bio GAAP EPS of -$0.13 beats by $0.05, revenue of $0.07M misses by $0.02M [5/12/2022 8:08 AM] |
2.09 | 0.09 (4.50%) |
0.0 | 0.0 (0.00%) |
1.72 - 8.68 | 47,943 | 20,000 | 0 | |
| 08-03-2022 | PM | ENTX | Entera Bio Ltd. | 39.20 | 0.21 | -0.11 | -0.11 | Entera Bio GAAP EPS of -$0.47 beats by $0.58, revenue of $0.57M beats by $0.03M [3/8/2022 6:44 AM] |
2.17 | -0.07 (-3.30%) |
0.0 | 0.0 (0.00%) |
1.38 - 10.16 | 23,138 | 30,000 | 0 | ||
| 10-11-2021 | PM | ENTX | Entera Bio | 96.00 | -0.05 | -0.10 | 0.00 | 3.74 | -0.29 (-7.20%) |
3.92 | -0.11 (-2.73%) |
1.01 - 10.16 | 309,994 | 60,000 | 494 | |||
| 16-08-2021 | PM | 8:00 AM ET (Aug 16) |
ENTX | Entera Bio Ltd. | 131.00 | -0.19 | -0.10 | 0.00 | Entera Bio EPS misses by $0.51, beats on revenue [8/16/2021 6:37 AM] |
5.04 | -0.36 (-6.67%) |
5.35 | -0.05 (-0.93%) |
1.00 - 10.16 | 228,245 | 280,000 | 3,685 | |
|
||||||||||||||||||
| 20-05-2021 | PM | ENTX | Entera Bio Ltd. | 55.25 | -0.43 | 0.00 | -0.16 | Entera Bio EPS misses by $0.31, beats on revenue; issues guidance [5/20/2021 9:46 AM] |
3.06 | 0.06 (1.83%) |
3.10 | 0.10 (3.33%) |
1.00 - 10.16 | 128,245 | 200,000 | 1,259 | ||
|
||||||||||||||||||
| 18-03-2021 | PM | 0:00 AM ET (Mar 18) |
ENTX | Entera Bio Ltd. | 105.94 | -0.11 | 0.00 | -0.26 | Entera Bio EPS beats by $0.01, beats on revenue [3/18/2021 8:07 AM] |
4.75 | -1.11 (-18.94%) |
5.36 | -0.50 (-8.53%) |
1.00 - 10.16 | 1,796,266 | 50,310,000 | 77,496 | |
| 19-11-2020 | PM | 0:00 AM ET (Nov 19) |
ENTX | Entera Bio Ltd. | 20.24 | -0.09 | 0.00 | -0.25 | Entera Bio EPS misses by $0.22 [11/19/2020 6:32 AM] |
1.05 | -0.06 (-5.83%) |
1.14 | 0.02 (2.24%) |
1.00 - 3.40 | 122,146 | 74,984 | 5,896 | |